Galapagos after u. S. Drug maker gilead doubles its stake with a 5. 1 billion investment. And rallies after being awarded 5. 8 billion in damages relating to a joint venture in pakistan and as the race heats up for the next managing director of the imf, the fund hosts an event on central and Eastern Europe. Ill be speaking shortly to the the deputy managing director of the fund well good morning, and happy monday i want to take you to some of the price Market Action that weve had over the last couple of hours or so on friday we had wall street close at record highs, but the news of the last 24 hours has been dominated by the gdp number that came out of china 6. 2 is the figure while some people are pointing to the fact that the gdp trend is the weakest in seven years, one its in line with expectations and fixed Asset Investment stronger than expectations, even retail sales for the month of june in china came in at 9. 8 versus 8. 3 expectations some of the details were a little stronger
UTRECHT, The Netherlands (BUSINESS WIRE) Sapreme, a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutics, today announced the appointment of experienced biopharmaceutical industry executives Jeanne Bolger, MD, and Andre Hoekema, PhD, to its Board of Directors. Both bri.
Sapreme Appoints Experienced Industry Executives, Dr Jeanne Bolger and Dr Andre Hoekema, to its Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Molecure S.A. ("Molecure": WSE: MOC) a clinical stage biotechnology company that uses its world leading medicinal capabilities to discover and.